Your browser doesn't support javascript.
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram, Varshitha Hemanth; Gupta, Roshmi; Adulkar, Namrata; Nair, Akshay Gopinathan; Bradoo, Renuka A; Hegde, Raghuraj; Singh, Usha; Tadepalli, Sameeksha; Mukherjee, Bipasha; Kamal, Saurabh; Alam, Md Shahid; Rao, Raksha; Ananthakrishna, Sushma; Backiavathy, Varsha; Murthy, Ajay Krishna; D'Cunha, Lynn; Dudeja, Gagan; Joji, Annie; Kiran, Anjali; Koka, Kirti; Goswami Mukhopadhyay, Moupia; Nisar, Sonam Poonam; Rao, Priyanka R; Shinde, Chhaya A.
  • Vasanthapuram VH; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Gupta R; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Adulkar N; Orbit & Oculoplasty Services, Sunayan Eye Care and Aesthetic Clinic, Pune, India.
  • Nair AG; Ophthalmic Plastic Surgery and Ocular Oncology Services, Aditya Jyot Eye Hospital, Mumbai, India.
  • Bradoo RA; Ophthalmic Plastic Surgery and Ocular Oncology Services, Advanced Eye Hospital & institute, Advanced Eye Hospital & Institute, Navi Mumbai India.
  • Hegde R; Department of Ophthalmology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai.
  • Singh U; Department of ENT, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai.
  • Tadepalli S; Orbit, Ophthalmic Plastic Surgery & Ophthalmic Oncology Service, Department of Ophthalmology, Manipal Hospital, Bangalore, India.
  • Mukherjee B; Department of Ophthalmic Plastic Surgery, Advanced Eye Centre, PGIMER, Chandigarh, India.
  • Kamal S; Department of Ophthalmic Plastic Surgery, Advanced Eye Centre, PGIMER, Chandigarh, India.
  • Alam MS; Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Sankara Nethralaya, Chennai, India.
  • Rao R; Orbit & Oculoplasty Services, EYEHUB, Faridabad, India.
  • Ananthakrishna S; Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Aditya Birla Sankara Nethralaya, Kolkata, India.
  • Backiavathy V; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Murthy AK; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • D'Cunha L; Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Sankara Nethralaya, Chennai, India.
  • Dudeja G; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Joji A; Department of Ophthalmology, Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai.
  • Kiran A; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Koka K; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Goswami Mukhopadhyay M; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Nisar SP; Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Sankara Nethralaya, Chennai, India.
  • Rao PR; Ophthalmic Plastic Surgery Services, Narayana Nethralaya, Bangalore, India.
  • Shinde CA; Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Sankara Nethralaya, Chennai, India.
Orbit ; : 1-12, 2022 Feb 22.
Article in English | MEDLINE | ID: covidwho-2226942
ABSTRACT

PURPOSE:

To study the risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis (ROCM) during the COVID-19 pandemic in India.

METHODS:

Multi-centric retrospective case-control study conducted from October 2020 to May 2021. Cases comprised of consecutive patients of COVID-19-associated ROCM (CA-ROCM) presenting at the participating ophthalmic institutes. Controls comprised of COVID-19-positive or COVID-19-recovered patients who did not develop ROCM. Comparative analysis of demographic, COVID-19 infection, treatment parameters and vaccination status between cases and controls performed. Clinical and imaging features of CA-ROCM analyzed.

RESULTS:

There were 179 cases and 361 controls. Mean age of presentation in cases was 52.06 years (p = .001) with male predominance (69.83%, p = .000011). Active COVID-19 infection at the time of presentation of ROCM (57.54%, p < .0001), moderate to severe COVID-19 (p < .0001), steroid administration (OR 3.63, p < .00001), uncontrolled diabetes (OR 32.83, p < .00001), random blood sugar >178 mg/dl were associated with development of CA-ROCM. Vaccination showed a protective effect (p = .0049). In cases with intracranial or cavernous sinus extension there was history of steroid administration (OR 2.89, p = .024) and orbital apex involvement on imaging (OR 6.202, p = .000037) compared to those with only rhino-orbital disease.

CONCLUSION:

Male gender, active COVID-19 infection, moderate or severe COVID-19, uncontrolled diabetes, steroid administration during COVID-19 treatment are risk factors for developing rhino-orbital-cerebral mucormycosis. Vaccination is protective. Random blood sugar of >178 mg/dl in COVID-19 positive or recovered patients should warrant close observation and early detection of ROCM. Presence of ophthalmoplegia, blepharoptosis at first clinical presentation and orbital apex involvement on imaging are associated with intracranial extension in ROCM.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Orbit Year: 2022 Document Type: Article Affiliation country: 01676830.2021.2020851

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Orbit Year: 2022 Document Type: Article Affiliation country: 01676830.2021.2020851